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Background
Protein kinase G type I (PKGI/cGMP kinase I) plays a
critical role in survival signalling of pre- and postcondi-
tioning. However, it is unclear whether cGKI exerts its
protective effects in the cardiomyocyte or if other car-
diac cell types are involved, and whether nitric oxide
(NO) has cGKI-independent effects on cardiomyocytes
mitochondria.
Objective
We developed mice with a cardiomyocyte-specific abla-
tion of the cGKI gene (CMG-KO) and tested whether
protection against reperfusion injury by ischemic post-
conditioning (IPost), soluble guanylyl cyclase (sGC) acti-
vation, the adenosine A2B receptor (A2BAR), or the
mitochondria-targeted S-nitrosothiol (MitoSNO) was
affected. MitoSNO accumulates within mitochondria,
driven by the membrane potential, where it generates
NO
￿ and S-nitrosated thiol proteins [1].
Methods and results
Conditional mice with floxed cGKI alleles were crossed
to the MLC2a-Cre transgenic mice. Western Blot and
immunohistochemistry confirmed that the Cre-mediated
recombination produced the cGKI knock-out specifically
in atrial and ventricular cardiomyocytes but not in other
organs (Figure 1).
In situ hearts of underwent 30 min of regional ische-
mia followed by 2 h of reperfusion. As expected, in the
control animals all interventions at early reperfusion
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Figure 1 Representative Western Blots of A left ventricle and B
cerebellum of CMG-KO and control mice from the same litters on a
C57/Bl6N genetic background (CMG-CTR), clearly indicating the
specific absence of cGKI in the heart. C Immunohistochemistry of
cardiac tissue.
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any medium, provided the original work is properly cited.lead to profound infarct size reduction: IPost (six cycles
of 10 sec reperfusion and 10 sec of coronary occlusion),
treatment with the specific sGC activator BAY 58-2667
(BAY58), the selective A2BAR agonist BAY 60-6583
(BAY60), as well as MitoSNO. In contrast, the hearts of
CMG-KO animals were not protected by BAY58,
whereas the protective effects of IPost, BAY60, and
MitoSNO were unaffected by the lack of cGKI.
Conclusion
While cardiomyocyte cGKI is important for the protec-
tion afforded via cGMP-signalling, beneficial effects of
IPost, activation of the A2BAR, as well as direct NO
effects via mitochondrial S-nitrosylation does not
depend on cGKI in cardiomyocytes.
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Figure 2 Results of open chest experiments. As expected, either
IPost, activation of sGC with BAY58 or A2BAR activation with BAY60
resulted in a profound decrease of infarct size in CMG-CTR. While
BAY58 failed to protect in the CMG-KO animals, IPost, BAY60, and
MitoSNO still afforded protection, suggesting a signaling
independent on cGKI in the cardiomyocyte. *p<0.05 vs. control.
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